TLR7 and lobular neoplasia: The activation of TLR7 using a synthetic TLR7 ligand is known to stimulate the systemic production of IFN and aggravate lupus nephritis (LN) in MRL/MpJ-fas lpr (MRL/lpr, lupus-prone mice) [14].